Cytometry Part B: Clinical Cytometry最新文献

筛选
英文 中文
Response to "Bridging the implementation gap in AI-assisted flow cytometry". 回应“弥合人工智能辅助流式细胞术的实施差距”。
IF 2.7 3区 医学
Cytometry Part B: Clinical Cytometry Pub Date : 2026-01-21 DOI: 10.1002/cytob.70009
Alice Yue, Ryan R Brinkman, Veronica Nash, Fabian Junker, Goce Bogdanoski, Anagha Divekar, Aaron Tyznik, Josef Spidlen, Wolfgang Kern, Jordi Petriz, Kaska Wloka, Kamila Czechowska
{"title":"Response to \"Bridging the implementation gap in AI-assisted flow cytometry\".","authors":"Alice Yue, Ryan R Brinkman, Veronica Nash, Fabian Junker, Goce Bogdanoski, Anagha Divekar, Aaron Tyznik, Josef Spidlen, Wolfgang Kern, Jordi Petriz, Kaska Wloka, Kamila Czechowska","doi":"10.1002/cytob.70009","DOIUrl":"https://doi.org/10.1002/cytob.70009","url":null,"abstract":"","PeriodicalId":10883,"journal":{"name":"Cytometry Part B: Clinical Cytometry","volume":" ","pages":""},"PeriodicalIF":2.7,"publicationDate":"2026-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146009141","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IF 2.7 3区 医学
Cytometry Part B: Clinical Cytometry Pub Date : 2026-01-07
{"title":"","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":10883,"journal":{"name":"Cytometry Part B: Clinical Cytometry","volume":"110 3","pages":"180-189"},"PeriodicalIF":2.7,"publicationDate":"2026-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148069068","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IF 2.7 3区 医学
Cytometry Part B: Clinical Cytometry Pub Date : 2025-12-17
{"title":"","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":10883,"journal":{"name":"Cytometry Part B: Clinical Cytometry","volume":"110 3","pages":"223-225"},"PeriodicalIF":2.7,"publicationDate":"2025-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148081546","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bridging the implementation gap in AI-assisted flow cytometry. 弥合人工智能辅助流式细胞术的实施差距。
IF 2.7 3区 医学
Cytometry Part B: Clinical Cytometry Pub Date : 2025-12-10 DOI: 10.1002/cytob.70002
Zekai Yu, Weihao Cheng, Siyi Liu
{"title":"Bridging the implementation gap in AI-assisted flow cytometry.","authors":"Zekai Yu, Weihao Cheng, Siyi Liu","doi":"10.1002/cytob.70002","DOIUrl":"https://doi.org/10.1002/cytob.70002","url":null,"abstract":"","PeriodicalId":10883,"journal":{"name":"Cytometry Part B: Clinical Cytometry","volume":" ","pages":""},"PeriodicalIF":2.7,"publicationDate":"2025-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145721583","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Issue Highlights—November 2025 发行亮点- 2025年11月
IF 2.7 3区 医学
Cytometry Part B: Clinical Cytometry Pub Date : 2025-11-29 DOI: 10.1002/cytob.70001
Sa Wang
{"title":"Issue Highlights—November 2025","authors":"Sa Wang","doi":"10.1002/cytob.70001","DOIUrl":"https://doi.org/10.1002/cytob.70001","url":null,"abstract":"","PeriodicalId":10883,"journal":{"name":"Cytometry Part B: Clinical Cytometry","volume":"108 6","pages":"427-429"},"PeriodicalIF":2.7,"publicationDate":"2025-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145626836","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Establishment of a flow cytometric platelet crossmatching assay and its clinical application in platelet refractoriness 流式细胞仪血小板交叉配型方法的建立及其在血小板难治性检测中的临床应用。
IF 2.7 3区 医学
Cytometry Part B: Clinical Cytometry Pub Date : 2025-11-19 DOI: 10.1002/cyto.b.22260
Dong Woo Shin, Jeong Eon Park, Yun Ji Hong, Kyoung Un Park
{"title":"Establishment of a flow cytometric platelet crossmatching assay and its clinical application in platelet refractoriness","authors":"Dong Woo Shin,&nbsp;Jeong Eon Park,&nbsp;Yun Ji Hong,&nbsp;Kyoung Un Park","doi":"10.1002/cyto.b.22260","DOIUrl":"10.1002/cyto.b.22260","url":null,"abstract":"<p>Platelet refractoriness is caused by antibodies against human leukocyte antigens or human platelet antigens. However, readily applicable assays that assist in selecting immunologically compatible platelet units remain limited. We established a flow cytometric platelet crossmatching assay and assessed its clinical utility by interpreting the results in conjunction with post-transfusion corrected count increments (CCI). Platelets were incubated with serum that may contain anti-platelet antibodies. Using flow cytometry, CD41-expressing platelets were gated, and the median fluorescence intensity (MFI) of fluorescein isothiocyanate (FITC)-conjugated anti-human IgG was measured. The MFI ratio was calculated as test sample MFI divided by baseline negative control MFI. The cutoff value and limit of detection (LoD) were estimated. Platelet crossmatching was performed using residual segments of transfused platelet units and patient serum, and the results were retrospectively interpreted in conjunction with CCIs and clinical findings. The MFI ratios were clearly distinguishable among the three groups: high-positive controls, low-positive controls, and known negative samples (<i>p</i> &lt; 0.001). The cutoff value was calculated to be 1.35, and the LoD was 1.53. In total, eight platelet transfusion events in five patients were analyzed. Four cases were interpreted as non-immune refractoriness, and the remaining four showed adequate post-transfusion platelet increments. All corresponding platelet crossmatching results were negative, which was considered appropriate given that the assay is designed to reflect immune refractoriness. The flow cytometric platelet crossmatching assay was established and demonstrated to be applicable. The assay can help predict transfusion outcomes in alloimmunized patients and contribute to the selection of compatible blood units.</p>","PeriodicalId":10883,"journal":{"name":"Cytometry Part B: Clinical Cytometry","volume":"110 1","pages":"39-46"},"PeriodicalIF":2.7,"publicationDate":"2025-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145556461","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Coexistent dual CD4+/CD8− and CD4−/CD8+ T-cell large granular lymphocytic leukemia in a young adult male: An exceedingly rare finding 双CD4+/CD8-和CD4-/CD8+ t细胞大颗粒淋巴细胞白血病在一个年轻成年男性:一个极其罕见的发现。
IF 2.7 3区 医学
Cytometry Part B: Clinical Cytometry Pub Date : 2025-11-17 DOI: 10.1002/cyto.b.22267
Devasis Panda, Narender Tejwani, Sabina Langer
{"title":"Coexistent dual CD4+/CD8− and CD4−/CD8+ T-cell large granular lymphocytic leukemia in a young adult male: An exceedingly rare finding","authors":"Devasis Panda,&nbsp;Narender Tejwani,&nbsp;Sabina Langer","doi":"10.1002/cyto.b.22267","DOIUrl":"10.1002/cyto.b.22267","url":null,"abstract":"","PeriodicalId":10883,"journal":{"name":"Cytometry Part B: Clinical Cytometry","volume":"110 1","pages":"57-59"},"PeriodicalIF":2.7,"publicationDate":"2025-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145539464","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Implementation of a one-tube flow cytometry panel for measurable residual disease detection in multiple myeloma patients in clinical routine 应用单管流式细胞仪检测多发性骨髓瘤患者可测量的残留病变。
IF 2.7 3区 医学
Cytometry Part B: Clinical Cytometry Pub Date : 2025-11-14 DOI: 10.1002/cyto.b.22264
Karin Deutsch-Biedermann, Katrin Hefler-Frischmuth, Judith Gruber, Christine Kimbacher, Isabella Herbring, Sigrid Machherndl-Spandl, Irene Strassl, Peter Bettelheim, Benjamin Dieplinger
{"title":"Implementation of a one-tube flow cytometry panel for measurable residual disease detection in multiple myeloma patients in clinical routine","authors":"Karin Deutsch-Biedermann,&nbsp;Katrin Hefler-Frischmuth,&nbsp;Judith Gruber,&nbsp;Christine Kimbacher,&nbsp;Isabella Herbring,&nbsp;Sigrid Machherndl-Spandl,&nbsp;Irene Strassl,&nbsp;Peter Bettelheim,&nbsp;Benjamin Dieplinger","doi":"10.1002/cyto.b.22264","DOIUrl":"10.1002/cyto.b.22264","url":null,"abstract":"<p>Multiparametric flow cytometry is a highly valuable method for the assessment of measurable residual disease (MRD) in multiple myeloma patients. The aim of the study was to evaluate a one-tube MRD panel on a DxFlex flow cytometer including all EuroFlow recommended immunophenotypic markers (i.e., cytoplasmic light chain kappa and lambda, CD19, CD27, CD38, CD45, CD56, CD81, CD117, CD138) extended by CD200 to a total of 11 fluorochromes in one tube. Bone marrow aspirates from clinical routine underwent an ammonium chloride-based bulk lysis, followed by staining the surface antibodies and, after permeabilization, kappa, and lambda light-chain intracellular staining. We acquired 1 × 10<sup>7</sup> cells per sample with a DxFlex flow cytometer. We determined the limit of detection (LOD) and lower limit of quantification (LLOQ) as recommended by the International Myeloma Working Group. For the clinical evaluation, 68 samples from 53 patients with multiple myeloma under or after treatment were analyzed with the one-tube MRD panel, and the results were compared with our routine plasma cell panel (RPCP). Six of the 68 samples were additionally sent to another laboratory to confirm our results with the contemporary EuroFlow next-generation flow (NGF) assay. For our novel one-tube MRD panel we determined a LOD of 0.00016% (1.6 × 10<sup>−6</sup>) and a LLOQ of 0.00059% (5.9 × 10<sup>−6</sup>). Out of 68 specimens, 55 (80.9%) showed concordant results between the MRD- and the RPC-panel. Thirteen (19.1%) specimens showed a distinct population of abnormal plasma cells with the MRD panel not detectable with the RPC panel. The six samples simultaneously measured with our novel one-tube MRD panel and the EuroFlow NGF assay showed concordant results. The novel one-tube MRD panel meets the quality specifications of the International Myeloma Working Group. Our clinical evaluation found higher sensitivity for the one-tube MRD panel when compared to our RPC panel and concordant results with the contemporary EuroFlow NGF assay. Therefore, our novel one-tube MRD panel is well-suited for detecting MRD in multiple myeloma patients.</p>","PeriodicalId":10883,"journal":{"name":"Cytometry Part B: Clinical Cytometry","volume":"110 1","pages":"22-28"},"PeriodicalIF":2.7,"publicationDate":"2025-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145512054","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Validation of a candidate international harmonisation protocol-compliant measurement procedure for reticulocyte counting using an erythrocyte gating strategy excluding the platelet component 使用红细胞门控策略排除血小板成分的网织红细胞计数的候选国际协调协议符合测量程序的验证。
IF 2.7 3区 医学
Cytometry Part B: Clinical Cytometry Pub Date : 2025-11-14 DOI: 10.1002/cyto.b.22265
Yutaka Nagai, Tomohiro Takeda, Hiromichi Matsushita, Tomoko Arai, Yoko Yatabe, Hiromitsu Yokota, Takayuki Mitsuhashi, Masatoshi Wakui, Yohko Kawai, Hiroshi Kondo
{"title":"Validation of a candidate international harmonisation protocol-compliant measurement procedure for reticulocyte counting using an erythrocyte gating strategy excluding the platelet component","authors":"Yutaka Nagai,&nbsp;Tomohiro Takeda,&nbsp;Hiromichi Matsushita,&nbsp;Tomoko Arai,&nbsp;Yoko Yatabe,&nbsp;Hiromitsu Yokota,&nbsp;Takayuki Mitsuhashi,&nbsp;Masatoshi Wakui,&nbsp;Yohko Kawai,&nbsp;Hiroshi Kondo","doi":"10.1002/cyto.b.22265","DOIUrl":"10.1002/cyto.b.22265","url":null,"abstract":"<p>The International Harmonisation Protocol (IHP) for Reticulocyte Percentage (%Retic) in CLSI-H44-A2 is a microscopic procedure performed on a new-methylene-blue-stained blood film (NMB-IHP). However, IHP-compliant Measurement Procedures (MPs) based on flow cytometry (FCM) are recommended for practical and accurately assigned reference values. Thiazole orange (TO) for nucleic acid staining and CD235a immunostaining for erythrocyte gating are currently widespread for MP using FCM (TO/CD235a-MP); however they have not been validated using NMB-IHP. We recently developed MP using FCM with anti-CD45/CD41a/CD61 antibodies, that are utilized for excluding platelets from the un-nucleated blood cell fraction to select erythrocytes (TO/CD41a/CD61-MP). The aim of this study is to validate TO/CD41a/CD61-MP for measurement of reticulocytes as an IHP-compliant MP. First, TO/CD235a-MP was validated as an IHP-compliant MP by comparing it with NMB-IHP. Then TO/CD41a/CD61-MP was compared with TO/CD235a-MP. The practical utility of TO/CD41a/CD61-MP was evaluated using XN-2000™(Sysmex) and Celltac G + ™(Nihon Kohden) hematology analyzers to assess the accuracy of different nucleic acid staining methods. We first confirmed that TO/CD235a-MP was consistent with NMB-IHP, then evaluated TO/CD41a/CD61-MP using TO/CD235a-MP. Regression analysis demonstrated consistency between TO/CD41a/CD61-MP and TO/CD235a-MP, thereby establishing TO/CD41a/CD61-MP as IHP-compliant MP. In the accuracy assessment, the correlation coefficients to TO/CD41a/CD61-MP were observed to be 0.97 for both hematology analyzers with %Retic ranging from 0.0 to 8.2. TO/CD41a/CD61-MP serves effectively as an IHP-compliant MP. This study provides the first empirical validation of FCM-based MPs.</p>","PeriodicalId":10883,"journal":{"name":"Cytometry Part B: Clinical Cytometry","volume":"110 1","pages":"47-56"},"PeriodicalIF":2.7,"publicationDate":"2025-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cyto.b.22265","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145511967","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CD200 expression in CD4+ T-cells: Diagnostic implications across T-cell lymphomas CD200在CD4+ t细胞中的表达:对t细胞淋巴瘤的诊断意义
IF 2.7 3区 医学
Cytometry Part B: Clinical Cytometry Pub Date : 2025-11-14 DOI: 10.1002/cyto.b.22266
Radu Chiriac, Marie Donzel, Valentin Pourchet, Lucile Baseggio
{"title":"CD200 expression in CD4+ T-cells: Diagnostic implications across T-cell lymphomas","authors":"Radu Chiriac,&nbsp;Marie Donzel,&nbsp;Valentin Pourchet,&nbsp;Lucile Baseggio","doi":"10.1002/cyto.b.22266","DOIUrl":"10.1002/cyto.b.22266","url":null,"abstract":"","PeriodicalId":10883,"journal":{"name":"Cytometry Part B: Clinical Cytometry","volume":"110 1","pages":"60-61"},"PeriodicalIF":2.7,"publicationDate":"2025-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145512037","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书